FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Metoclopramide Injection, USP
Status: Currently in Shortage
»Date first posted: 10/23/2017
»Therapeutic Categories: Gastroenterology

Expand all

Fresenius Kabi USA, LLC (Reverified 11/17/2017)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg per 2 mL, single use, prefilled syringe (NDC 76045-101-20) Backordered. Next release anticipated January 2018. Demand increase for the drug

Hospira, Inc. (Revised 11/13/2017)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg/mL; 10 mg/2 mL Single Dose Glass Fliptop Vial (NDC 0409-3414-01) Next delivery: Early November 2017. Estimated recovery: March 2018 Shortage per Manufacturer: Manufacturing Delay Other

Teva Pharmaceuticals (New 10/24/2017)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg/ 1 ml (NDC 0703-4502-04) Teva has limited inventory due to capacity constraints. Recovery from the supply issue is expected in 2018. Other
5 mg/ 1 ml (NDC 0703-4502-84) Teva has limited inventory due to capacity constraints. Recovery from the supply issue is expected in 2018. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English